SecBot SecBot

BIOT

INSTINCT BIO TECHNICAL CO HOLDINGS INC.
Nasdaq· Perfumes, Cosmetics & Other Toilet Preparations· Inc. E9· CIK 0002072188 Consumer & Retail
$0.1900 +0.01 (+5.56%)
Oct 26 4:00 PM ET · prev $0.1800
Market cap
$5.9M
Nano cap
Since first trade
−98.8%
from $15.50 · Jul 24
30 days
−51.3%
from $0.3900
Range since listing
$0.1800–15.50
−99% from high · low Oct 23
Avg volume 20D
504.4K
shares / day
Short interest
🔒 Subscribers only
Filing reports
5
analyzed by SecBot
SecBot read BEARISH 5 reports · 90 days
Balance 1 bearish · 0 bullish · 1 mixed · 3 neutral oldest → newest, height = score
Avg score ·High conf. 2/5
Strongest MIXED BIOT reported first-half fiscal 2026 results for its operating group: revenue of $1,142,598 (+4.7% USD…
All reports →

Price

Daily candles with volume. Pins mark insider trades, rating changes, 13F stakes, reports, catalysts and short-interest jumps.

Signal stack

Where each data set points today.

  • TrendDOWNTREND

    48% below its 50-day average. New closing low $0.1800 on Oct 23.

Recent activity
The latest filings, insider trades, analyst actions, press and options flow — newest first.
Oct 16, 2026 SEC
BIOT reported first-half fiscal 2026 results for its operating group: revenue of $1,142,598 (+4.7% USD, +9.8% in yen)…
6-K — Impact 5/10
Oct 1, 2026 SEC
BIOT announced a non-exclusive appointment by CelSiege Biosciences as its authorized business development…
6-K — Impact 3/10
Sep 16, 2026 Listing status
Listing Status: BIOT — Deficient (was Normal)
Instinct Bio Technical Company Holdings Inc. - Common stock | Nasdaq Financial Status Indicator N →
Sep 15, 2026 SEC
Instinct Bio disclosed receiving three separate Nasdaq deficiency notices on September 9-10, 2026: failure to maintain…
6-K — Impact 7/10
Catalysts
Scheduled dates and disclosed events: earnings, FDA and trial readouts, halts, press releases. Colored dot = impact.
Recent
Sep 16, 2026
Listing
Listing Status: BIOT — Deficient (was Normal)
Instinct Bio Technical Company Holdings Inc. - Common stock | Nasdaq Financial Status Indicator N → D
Sep 4, 2026
Dividend
INSTINCT BIO Provides Operational Update on Indonesia Growth Platform and Product Development Initiatives
Instinct Bio (Nasdaq: BIOT) updates on its Jakarta GENRÊVER CLINIC site, subscription tiers, and cosmetic product candidates with INVITRX and PARVA.
Jul 27, 2026
Trading halt
Halt Resumed: BIOT — trading resumed after LUDP (Volatility Trading Pause)
Halted 2026-07-27T14:04:08.000Z | Resumed 2026-07-27T14:14:08.000Z
Jul 27, 2026
Trading halt
Trading Halt: BIOT — LUDP (Volatility Trading Pause)
Instinct Bio Tech Ord Sh | Market: NASDAQ | Code: LUDP — Volatility Trading Pause
Jul 27, 2026
Trading halt
Halt Resumed: BIOT — trading resumed after LUDP (Volatility Trading Pause)
Halted 2026-07-27T13:53:40.000Z | Resumed 2026-07-27T14:03:40.000Z

Earnings setup

Estimates
PeriodEPS est.Range30D rev.Revenue
Current Q———$0.00
Next Q———$0.00
Current FY———$0.00
Next FY———$0.00

Short side

FINRA· Oct 15, 2026
🔒 Subscribers only
shares short
Trading halts
Jul 27, 2026Volatility PauseResumed
Jul 27, 2026Volatility PauseResumed
Jul 27, 2026Volatility PauseResumed
Jul 24, 2026Volatility PauseResumed
Jul 24, 2026Volatility PauseResumed

SecBot reports

5 filings · 0 bullish · 1 bearish · 1 mixed · 3 neutral
All BIOT filing & press-release reports (5)